Beyond the Foggy Supply Chain - Pharmaceutical Executive


Beyond the Foggy Supply Chain
More control over warehouse data (from drug company to pharmacist) is key to inventory control

Pharmaceutical Executive

The transition from a make-to-stock environment to a demand-driven model requires organization-wide support and a commitment to following the demand signal and a single forecast. It also depends on a solid IT infrastructure that enables the flow of critical operational data across the organization and provides the analytic capabilities needed to make informed and actionable decisions based on that information. These ingredients, when combined and managed carefully, yield a powerful formula for continued success.

John Danese, product strategy director of life sciences at Oracle, contributed to this story.

Dennis Constantinou is senior industry director, life sciences at Oracle. He can be reached at

Arvindh Balakrishnan is senior director of life sciences industry business unit at Oracle. He can be reached at


blog comments powered by Disqus

Source: Pharmaceutical Executive,
Click here